Why the study?
To investigate how hypertrophic stimulation with endothelin-1 affects human induced pluripotent stem cell-derived cardiomyocytes.
Does endothelin-1 stimulation induce a time-dependent hypertrophic phenotype and transcriptional response in human iPSC-derived cardiomyocytes?
Does endothelin-1 stimulation induce a time-dependent hypertrophic phenotype and transcriptional response in human iPSC-derived cardiomyocytes?
This study establishes a characterized human iPSC-derived cardiomyocyte model of endothelin-1-induced cardiac hypertrophy over a 96-hour time course that recapitulates key morphological, metabolic, protein, and transcriptomic hallmarks for preclinical drug discovery.
Answers are grounded in this paper and cite their sources.
Establishes hiPSC-CMs as a hypertrophy model; extends preclinical tools but leaves clinical translation open.
models. In this study, we investigated how hypertrophic stimulation affected human induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CMs). The cells were stimulated with endothelin-1 (ET-1) for 8, 24, 48, 72, or 96 h. Parameters including cell size, ANP-, proBNP-, and lactate concentration were analyzed. Moreover, transcriptional profiling using RNA-sequencing was performed to identify differentially expressed genes following ET-1 stimulation. The results show that the CMs increase in size by approximately 13% when exposed to ET-1 in parallel to increases in ANP and proBNP protein and mRNA levels. Furthermore, the lactate concentration in the media was increased indicating that the CMs consume more glucose, a hallmark of cardiac hypertrophy. Using RNA-seq, a hypertrophic gene expression pattern was also observed in the stimulated CMs. Taken together, these results show that hiPSC-derived CMs stimulated with ET-1 display a hypertrophic response. The results from this study also provide new molecular insights about the underlying mechanisms of cardiac hypertrophy and may help accelerate the development of new drugs against this condition.
No takes yet. Share an insight, caveat, or question.
Johansson et al. (2020) studied Cardiac hypertrophy (in vitro human iPSC-derived cardiomyocyte model). Endothelin-1 (ET-1) vs. Unstimulated control cardiomyocytes incubated with corresponding volume of DMSO vehicle was evaluated on Cardiomyocyte cell volume increase at 48, 72, and 96 hours (MD 0.87 µm³ (13% increase), p=<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: